As of Jul 31
| +0.21 / +6.48%|
The 4 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +88.41% increase from the last price of 3.45.
The current consensus among 4 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.